As of March 31, 2026, the Company’s investment portfolio included 15 loans, comprised of first lien senior term loans that are geographically headquartered in the United States. The aggregate commitment under these loans was approximately $375.7 million and outstanding principal was approximately $356.6 million as of March 31, 2026. For the three months ended March 31, 2026, the Company funded $80.6 million of new loans and additional principal and received approximately $41.8 million of principal repayments.

As of March 31, 2026, on a fair value basis, 59.3% of performing debt investments bore interest at a floating rate and 40.7% of performing debt investments bore interest at a fixed rate, respectively.


	As of March 31, 2026
	Amortized cost(1)		Fair Value(2)

First lien senior term loans	$	345,918,978	$	279,237,624
Total investments	$	345,918,978	$	279,237,624

(1)The difference between the amortized cost and the outstanding principal amount of the loans consists of unaccreted original issue discount (“OID”) and loan origination costs.

The Company uses Global Industry Classification Standards for classifying the industry groupings of its portfolio companies. The industrial composition of the Company’s portfolio at fair value as of March 31, 2026 were as follows:


	As of March 31, 2026
Investment Type	Fair Value		% of Total Investments at Fair Value

Cannabis	$	201,120,634	72.0	%
Insurance	19,876,990		7.1	%
Commercial & Professional Services	58,240,000		20.9	%
Total investments	$	279,237,624	100.0	%

As of March 31, 2026, the Company had certain investments in three portfolio companies on nonaccrual status, which represented 23.5% of total debt investments at fair value. As of March 31, 2026, investments on nonaccrual status had an aggregate amortized cost and fair value of approximately $126.5 million and $65.8 million, respectively.